Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Christoph Reißfelder

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4591-1046; OpenAlex author ID A5035586224. Sources: OpenAlex.

Their work

Papers
19 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
71
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 3 papers · 2018: 1 paper · 2019: none · 2020: 6 papers · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers

Papers 19

  1. Perioperative outcomes in an age-adapted analysis of the German StuDoQ|Pancreas registry for PDAC. Co-author DOI 10.1186/s12893-024-02647-1↗
  2. Punching Above Its Weight: A Head-to-Head Comparison of Deepseek-R1 and OpenAI-o1 on Pancreatic Adenocarcinoma-Related Questions. Co-author DOI 10.7150/ijms.118887↗
  3. A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patients. Co-author DOI 10.1007/s00423-024-03570-y↗
  4. PDCD10 promotes the tumor-supporting functions of TGF-β in pancreatic cancer. Co-author DOI 10.1042/cs20240450↗
  5. Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines. Co-author DOI 10.3390/ijms241713530↗
  6. Author Correction: Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Co-author DOI 10.1038/s41586-022-05062-9↗
  7. Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study. Co-author DOI 10.1186/s12885-022-09731-w↗
  8. Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels. Co-author DOI 10.1038/s41388-020-1186-7↗
  9. Impact of intraoperative margin clearance on survival following pancreatoduodenectomy for pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.1038/s41598-020-79252-8↗
  10. PD-1 Expression by Lymph Node and Intratumoral Regulatory T Cells Is Associated with Lymph Node Metastasis in Pancreatic Cancer. Co-author DOI 10.3390/cancers12102756↗
  11. GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer. Co-author DOI 10.3390/cancers12123774↗
  12. Characterization of Stem-like Circulating Tumor Cells in Pancreatic Cancer. Co-author DOI 10.3390/diagnostics10050305↗
  13. Obesity and Pancreatic Cancer: A Matched-Pair Survival Analysis. Co-author DOI 10.3390/jcm9113526↗
  14. Validation of prognostic risk scores for patients undergoing resection for pancreatic cancer. Co-author DOI 10.1016/j.pan.2018.05.005↗
  15. Impact of Intraoperative Re-resection to Achieve R0 Status on Survival in Patients With Pancreatic Cancer: A Single-center Experience With 483 Patients. Co-author DOI 10.1097/sla.0000000000001808↗
  16. Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer. Co-author DOI 10.1186/s12885-017-3225-5↗
  17. Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection. Last author DOI 10.18632/oncotarget.20315↗
  18. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Co-author DOI 10.1038/nature14581↗
  19. Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer. Co-author DOI 10.1186/1471-2407-11-134↗

Closest collaborators

The 25 strongest of 71 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nuh N. Rahbari · 9 shared papers, 2015–2024 · strength 0.95
  2. Cui Yang · 4 shared papers, 2017–2025 · strength 0.59
  3. Emrullah Birgin · 3 shared papers, 2020–2024 · strength 0.51
  4. Felix Rückert · 3 shared papers, 2020–2023 · strength 0.42
  5. Jürgen Weitz · 6 shared papers, 2011–2020 · strength 0.41
  6. Thilo Welsch · 5 shared papers, 2017–2020 · strength 0.40
  7. Christoph Kahlert · 5 shared papers, 2015–2022 · strength 0.39
  8. Jens Werner · 3 shared papers, 2011–2025 · strength 0.38
  9. Marius Distler · 4 shared papers, 2017–2022 · strength 0.38
  10. Sebastian Schölch · 4 shared papers, 2017–2020 · strength 0.36
  11. Tobias Keck · 2 shared papers, 2024–2025 · strength 0.36
  12. Michael B. Ghadimi · 2 shared papers, 2024–2025 · strength 0.36
  13. Soeren Torge Mees · 2 shared papers, 2024–2025 · strength 0.36
  14. Waldemar H. Uhl · 2 shared papers, 2024–2025 · strength 0.36
  15. Chengpeng Li · 1 shared paper, 2025 · strength 0.28
  16. Qianwen Zhou · 1 shared paper, 2024 · strength 0.26
  17. Patrick Téoule · 2 shared papers, 2020 · strength 0.25
  18. Lei Zhu · 2 shared papers, 2020 · strength 0.24
  19. Balázs Győrffy · 2 shared papers, 2020 · strength 0.24
  20. Tengis Tschaidse · 1 shared paper, 2025 · strength 0.22
  21. Heinz Johannes Buhr · 1 shared paper, 2025 · strength 0.22
  22. Bernhard Willibald Renz · 1 shared paper, 2025 · strength 0.22
  23. Matthias Ilmer · 1 shared paper, 2025 · strength 0.22
  24. Jan Goesta D’Haese · 1 shared paper, 2025 · strength 0.22
  25. Adrian M. Seifert · 2 shared papers, 2020 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.